Urothelial carcinoma in the prostatic urethra and prostate: current controversies.
Liedberg F, Chebil G, Månsson W.
Expert Rev Anticancer Ther. 2007 Mar;7(3):383-90. doi: 10.1586/14737140.7.3.383.
ESMO Clinical Practice Guideline interim update on first-line therapy in advanced urothelial carcinoma.
Powles T, Bellmunt J, Comperat E, De Santis M, Huddart R, Loriot Y, Necchi A, Valderrama BP, Ravaud A, Shariat SF, Szabados B, van der Heijden MS, Gillessen S; ESMO Guidelines Committee. Electronic address: clinicalguidelines@esmo.org.
Ann Oncol. 2024 Jun;35(6):485-490. doi: 10.1016/j.annonc.2024.03.001. Epub 2024 Mar 13.
Primary high-grade urothelial carcinoma of prostate with prostatic hyperplasia: a rare case report and review of the literature.
Liu L, Sun FZ, Zhang PY, Xiao Y, Yue X, Wang DM, Wang Q.
Aging Male. 2023 Dec;26(1):2252102. doi: 10.1080/13685538.2023.2252102.
[Prostatic involvement by urothelial carcinoma in patients with bladder cancer and their implications in the clinical practice].
Huguet J.
Actas Urol Esp. 2012 Oct;36(9):545-53. doi: 10.1016/j.acuro.2012.02.005. Epub 2012 Apr 19.
Metastatic primary urothelial carcinoma of the prostatic urethra: A case report.
Kisa E, Semiz HS, Küçük Ü, İlbey YÖ.
Urologia. 2019 Aug;86(3):161-164. doi: 10.1177/0391560318808631. Epub 2018 Oct 30.
Nephrogenic Adenoma Intermixed With Urothelial Carcinoma.
Kryvenko ON, Wasco MJ, Williamson SR.
Arch Pathol Lab Med. 2022 May 1;147(5):552-558. doi: 10.5858/arpa.2021-0620-OA.
[Metastatic lymph node collision of a prostatic adenocarcinoma and an urothelial carcinoma and review of the literature].
Junca A, Frouin E, Irani J, Fromont G, Levillain P.
Ann Pathol. 2015 Dec;35(6):496-501. doi: 10.1016/j.annpat.2015.09.005. Epub 2015 Nov 17.
Invasive high-grade urothelial carcinoma of the bladder, renal pelvis, ureter, and prostatic urethra arising in a background of urothelial carcinoma with an inverted growth pattern: a contemporary clinicopathological analysis of 91 cases.
Gutierrez CM, Alemozaffar M, Osunkoya AO.
Hum Pathol. 2019 Oct;92:18-24. doi: 10.1016/j.humpath.2019.07.005. Epub 2019 Jul 24.
Immunophenotype of high-grade prostatic adenocarcinoma and urothelial carcinoma.
Genega EM, Hutchinson B, Reuter VE, Gaudin PB.
Mod Pathol. 2000 Nov;13(11):1186-91. doi: 10.1038/modpathol.3880220.
Prostatic adenocarcinoma with urothelial (transitional cell) carcinoma features.
Mai KT, Collins JP, Veinot JP.
Appl Immunohistochem Mol Morphol. 2002 Sep;10(3):231-6. doi: 10.1097/00129039-200209000-00008.
